INDEX 



603 



Suprarenal capsules, experimental ex- 

 tirpation, death following, 142 



, followed by toxicity of 



blood, 156 



. , followed by toxicity of 

 muscles and viscera, 156 



, organotherapy after, 165- 



168 



, symptoms, 153-158 



, fat-contents, distribution, 285 



. - , ferments in, 275 



, functions of, historical account 



of discoveries, 124-127 

 . . , in relation to muscular 

 fatigue, 295 

 , suppression chronic, 159 



, due to haemorrhage into 



organ, 159 



, symptom - com- 

 plex, 159 



in man, 158 



, symptoms, 153-158 



, hypersecretion, experimental, 



260 ; see also Hyperadrenalism 

 , hypertrophy in pseudo-herma- 

 phroditism, 269 



, hypofunction, 261 



, hypoplastic infantilism of, 158 

 . in adder, 298 



in Batrachians, 299 



in birds, 299, 300 



, indispensable to life, 17 



- in fish, extirpation not fatal, 



IS - 2 ' I53 t A 

 , mnervation, physiology of, 260 



-in Selachians, 299 



, lecithin in, 286 



, lipoids in, 279, 287, 292, 293 



, medulla of, 128, 131 



, experimental extirpation, 



146-150 

 , hyperplasia of chromaffine 



tissue, 262 



, quantitative value, 265 



, over-estimated, 265 



, secretory processes, morph- 

 ology, 252 



. , total aplasia of, 158 



, not homogeneous organs, 127 



of pigs, distillation with hot 



acetone, 290, 291 

 , lipoid substances in, 290, 



291 

 of rabbits, amorphous masses 



in, 284 



, physiology of, 134, 138 



, portal system, 298, 299 



in birds, 300 



in reptiles, 299 



, primary disease, rare, 159 



, reaction to adrenalin, 212 



, reduction in size of, 158 



, relationship to hypophysis, 339 



, secretory process of, 251 



, sound, but with clinical signs 



of Addison's disease, 159, 160 



40 



Suprarenal capsules, stimulation, ex- 

 perimental, 260 



, substitution, 165 



. , transplantation, 168 



- , functional capacity, 171 



, histological observations, 

 169 



, regression and proliferation 



of tissue following, 170, 171 



- , site of, 170, 171, 172 



, successful, 170 



-, conditions for, 173 



, tuberculosis of both, typical 



feature of Addison's disease, 150 



. , vascularization of, 298 



, weight of, increased after cas- 

 tration, 269 



, increase during pregnancy, 



269 

 -in different animals, 269 



extract, blood-pressure increased 



by, how abolished, 157 



in Addison's disease, 168 



. , physiological action of, 173, 



174 

 , specific action centred in 



adrenal body, 247 



, toxic action, 175, 176 



, watery, intravenous injection, 



177; see also Adrenalin 



organs, accessory, 131, see also 



Interrenal bodies, accessory 



systems in invertebrates, tables 



illustrating, 135-13? 

 Suprarenin, 178 

 , d, toxic dose, 237 

 , 1, foxic dose, 237 

 , synthetic racemic, 179 

 Sugar in urine, see ulycosuria 

 Surgery, operative, knowledge as to 



internal secretions obtained 



through, 17 

 Sweat glands, action of adrenalin on, 



214 

 , mnervation or, 191, 195 



TACHYCARDIA, following administration 



of thyroid extracts, 90 

 Temperature, bodily, modified by 



action of adrenalin, 226 

 Testicle, cryptorchidic, 393 

 , development of, 366, 369, 371 

 , secretory elements of, 392 

 , watery extract, 21 

 Testicular extract, effects of, 389 



, injection of, effect, 4 



Tetania parathyropriva, 38, 39, 47 

 Tetany, acute, experimental, 37, 39, 40 

 , milk diet in, 107 



, secondary symptoms following, 



43 



, tuberculosis and, 46 



, chronic, experimental production, 



43 



, experimental, albuminuria accom- 

 panying, 43 



